AMPA receptor antagonists claimed for epilepsy, muscle spasms and neurodegenerative disorders March 23, 1999
Potent, orally active CRF antagonist with anxiolytic activity reported by DuPont at ACS meeting March 22, 1999
FDA approves first product specifically for pain associated with postherpetic neuralgia March 22, 1999
RSS